Jiangsu Nhwa Pharmaceutical Co Ltd Net Asset Quality Index
Jiangsu Nhwa Pharmaceutical Co Ltd net asset quality index. Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Net Asset Quality Index of 87.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.54 Billion minus total liabilities of CN¥1.17 Billion yields net assets of CN¥8.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Jiangsu Nhwa Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Net asset quality index of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. This chart shows how Jiangsu Nhwa Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of June 2026, the index stands at 87.7%, representing net assets of CN¥8.36 Billion against total assets of CN¥9.54 Billion CNY. Check Jiangsu Nhwa Pharmaceutical Co Ltd (002262) strategic asset index to assess the company's strategic physical and investment asset allocation.
Jiangsu Nhwa Pharmaceutical Co Ltd Net Asset Quality Index by Year (2005–2025)
Jiangsu Nhwa Pharmaceutical Co Ltd net asset quality index by year from 2005 to 2025. The table below presents the year-by-year Net Asset Quality Index for Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Jiangsu Nhwa Pharmaceutical Co Ltd (002262) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.0% | CN¥8.03 Billion | CN¥9.22 Billion | CN¥1.20 Billion | ▲ +0.9 pp |
| 2024 | 86.2% | CN¥7.27 Billion | CN¥8.44 Billion | CN¥1.17 Billion | ▼ -1.3 pp |
| 2023 | 87.5% | CN¥6.41 Billion | CN¥7.33 Billion | CN¥918.09 Million | ▲ +1.3 pp |
| 2022 | 86.2% | CN¥5.58 Billion | CN¥6.48 Billion | CN¥897.43 Million | ▲ +0.1 pp |
| 2021 | 86.1% | CN¥4.90 Billion | CN¥5.70 Billion | CN¥793.45 Million | ▲ +0.8 pp |
| 2020 | 85.3% | CN¥4.11 Billion | CN¥4.81 Billion | CN¥706.67 Million | ▼ -0.5 pp |
| 2019 | 85.8% | CN¥3.60 Billion | CN¥4.20 Billion | CN¥596.68 Million | ▲ +12.4 pp |
| 2018 | 73.4% | CN¥2.96 Billion | CN¥4.03 Billion | CN¥1.07 Billion | ▼ -1.2 pp |
| 2017 | 74.6% | CN¥2.46 Billion | CN¥3.30 Billion | CN¥840.24 Million | ▲ +3.2 pp |
| 2016 | 71.4% | CN¥2.12 Billion | CN¥2.97 Billion | CN¥850.97 Million | ▼ -0.2 pp |
| 2015 | 71.6% | CN¥1.83 Billion | CN¥2.55 Billion | CN¥723.60 Million | ▲ +16.6 pp |
| 2014 | 55.1% | CN¥1.06 Billion | CN¥1.92 Billion | CN¥863.61 Million | ▲ +1.7 pp |
| 2013 | 53.4% | CN¥836.21 Million | CN¥1.57 Billion | CN¥730.13 Million | ▲ +2.6 pp |
| 2012 | 50.7% | CN¥682.44 Million | CN¥1.34 Billion | CN¥662.41 Million | ▼ -0.1 pp |
| 2011 | 50.8% | CN¥556.01 Million | CN¥1.09 Billion | CN¥537.59 Million | ▲ +2.4 pp |
| 2010 | 48.5% | CN¥462.56 Million | CN¥954.30 Million | CN¥491.74 Million | ▼ -2.3 pp |
| 2009 | 50.7% | CN¥396.00 Million | CN¥780.68 Million | CN¥384.68 Million | ▲ +3.6 pp |
| 2008 | 47.1% | CN¥343.75 Million | CN¥729.41 Million | CN¥385.66 Million | ▲ +21.6 pp |
| 2007 | 25.5% | CN¥152.39 Million | CN¥596.78 Million | CN¥444.39 Million | ▲ +1.2 pp |
| 2006 | 24.3% | CN¥122.67 Million | CN¥504.30 Million | CN¥381.63 Million | ▼ -1.7 pp |
| 2005 | 26.0% | CN¥125.74 Million | CN¥482.86 Million | CN¥357.12 Million | — |